background
background
BCRX
Biocryst Pharma Inc
$6.82
+0.41
+6.40%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down
Monday
February 24, 2025
7:00 AM ET
BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
Monday
February 10, 2025
7:00 AM ET
BioCryst to Report Fourth Quarter 2024 Financial Results on February 24
Friday
January 10, 2025
7:00 AM ET
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
Monday
November 4, 2024
7:00 AM ET
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
Monday
October 21, 2024
7:00 AM ET
BioCryst to Report Third Quarter 2024 Financial Results on November 4